SARASOTA, FL -- (MARKET WIRE) -- April 11, 2007 -- DNAPrint® Genomics, Inc. (OTCBB: DNAG) today announced that it will be filing a registration statement with the Securities and Exchange Commission to register 150,000,000 shares to be issued under an Investment Agreement with Dutchess Private Equities Fund, Ltd. (“Dutchess”). The Dutchess Agreement provides that, from time to time, DNAPrint may deliver a notice to Dutchess and Dutchess will purchase DNAPrint shares based upon the parameters of the agreement.
